Nxgenport
1 known investors
NXgenPort is developing a smart implantable chemotherapy port that integrates optical sensing and machine learning to monitor blood cell dynamics and other physiological changes in vivo, paired with a digital health platform for data analysis. It targets oncology care teams and cancer patients, aiming to detect treatment complications like infection and neutropenia early for remote patient monitoring.
Founders & leadership
CS
Cathy SkinnerCo-founder/Co-inventor & Chief Executive Officer
RW
Rosanne WelcherCo-founder/Co-inventor & Chief Operating Officer